# IV Ketamine vs. Spravato: Which Is Right for You? > IV ketamine or Spravato? A side-by-side look at cost, insurance, dosing and results for treatment-resistant depression, by Seda A. Port, NP. - Type: post - URL: https://zenintegrativecare.com/ketamine-vs-spravato/ - Updated: 2026-08-29T01:16:59+00:00 ## About this page IV ketamine or Spravato? A side-by-side look at cost, insurance, dosing and results for treatment-resistant depression, by Seda A. Port, NP. ## Key facts - Phone: +1 (516) 610-0604 - Email: info@zenintegrativecare.com - Location: Carle Place, NY - Serving: Long Island, NY · New York City, NY · Nassau County, NY · Suffolk County, NY - Logo: /storage/projects/30/files/assets/852c08b1aec16f9a.webp ## Page content ## IV Ketamine vs. Spravato: Which Is Right for You? By Seda A. Port, NPApr 20, 2026 Choosing the right path for treatment-resistant depression or chronic anxiety is a deeply personal decision that often comes after years of trial and error with traditional medications. In recent years, two primary options have emerged within the field of glutamate-based medicine: intravenous (IV) ketamine infusions… ## The Core Question The central question for many patients is whether they should opt for the highly controlled, 100% bioavailable intravenous route or the FDA-approved nasal spray that often comes with insurance support. While both treatments utilize a similar chemical foundation, they are delivered differently, regulated differently… It is important to recognize that neither treatment is a “magic pill.( stand-alone solution)” Both require a supportive clinical environment and proper medical supervision. However, the patient experience varies significantly between an office-based infusion and a patient-administered nasal spray under direct medical… ## Background and Context Ketamine has been used safely in surgical settings as an anesthetic for over fifty years. In the early 2000s, clinical researchers discovered that sub-anesthetic doses of the drug could rapidly alleviate symptoms of depression and suicidal ideation. This discovery led to the rise of IV ketamine clinics across the… Spravato, or esketamine, was developed by Janssen Pharmaceuticals as a response to the need for a standardized, FDA-approved version of ketamine. In 2019, the FDA approved Spravato for treatment-resistant depression and later for depressive symptoms in adults with acute suicidal ideation or behavior. Spravato is the… ## The Key Facts When evaluating these two options, several technical and logistical factors stand out. Understanding these pillars of care can help demystify the process of starting ketamine therapy. - Bioavailability: IV ketamine provides 100% bioavailability, meaning the entire dose enters the bloodstream immediately and consistently. Spravato has a lower… - Insurance Coverage: Spravato is frequently covered by most major insurance providers and Medicare, provided the patient meets specific criteria for… - FDA Status: Spravato is FDA-approved specifically for treatment-resistant depression and major depressive disorder with suicidal ideation. IV ketamine is used… - Dosing Precision: IV infusions allow for precise, weight-based dosing that can be adjusted during the session if the patient experience is too intense or not… - Onset and Efficacy: Clinical studies have shown that both methods are effective, but some research suggests that the racemic ketamine found in IV infusions may… ## Related - [Ketamine Safety, Side Effects, and Who Should Avoid It](https://zenintegrativecare.com/ketamine-safety-side-effects/) - [What to Expect at Your First Ketamine Therapy Session](https://zenintegrativecare.com/first-ketamine-therapy-session-what-to-expect/) - [How Ketamine Works in the Brain: A Patient-Friendly Guide](https://zenintegrativecare.com/how-ketamine-works-brain/) - [The Role of Integration Therapy After Ketamine Treatment](https://zenintegrativecare.com/integration-therapy-after-ketamine/) - [Long Island Mental Health Resources: A 2026 Directory](https://zenintegrativecare.com/long-island-mental-health-resources/)